LOCALLY ADVANCED BREAST CANCER

Clinical trials for LOCALLY ADVANCED BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED BREAST CANCER trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 5 Completed 5 Terminated 1

New targeted drug combo aims to shrink tumors before surgery, spare patients harsh chemo

Disease control Not yet recruiting

This study is testing a new combination of two targeted drugs, SHR-A1811 and pertuzumab, given before surgery for a specific type of breast cancer that is both hormone receptor-positive (HR+) and HER2-positive. The goal is to see if this approach can effectively shrink or elimina…

Matched conditions: LOCALLY ADVANCED BREAST CANCER

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

LOCALLY ADVANCED BREAST CANCER

Get alerted when new LOCALLY ADVANCED BREAST CANCER trials appear

New targeted drug combo aims to shrink tumors before surgery, spare patients harsh chemo